MDM2 and neuroblastoma: For example, the co-amplification and resulting overexpression of MDM2/CDK4/FRS2 in neuroblastoma patient M787AAA is clinically relevant [48], and the fusions originating from this amplification are more likely to be passenger events [37, 49].